Oncoceutics competitors and similar companiesClear all
Oncoceutics's competitors and similar companies include PLIVA and Deciphera Pharmaceuticals.
 Oncoceutics Oncoceutics is a drug discovery and development company focused on selective G protein-coupled receptor antagonists for oncology.
|  PLIVA PLIVA HRVATSKA is a pharmaceutical company focused on the development of generic and niche products. |  Deciphera Pharmaceuticals Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer. | |
Founding Date | Founding Date 2009 | Founding Date 1921 | Founding Date 2003 |
Type | Type Subsidiary | Type Subsidiary | Type Public |
Tags | |||
Locations | Locations Philadelphia, US HQ | Locations Zagreb, HR HQ | Locations Waltham, US HQ Lawrence, US |
Employees | Employees 12 | Employees 1,5591% increase | Employees 35037% increase |
Twitter followers | Twitter followers 313 | Twitter followers 1 k | Twitter followers 748 |
Number of tweets (last 30 days) | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 32 | Number of tweets (last 30 days) 4 |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 3.8 | Average likes per tweet (last 30 days) 4.3 |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 100% |
Employee Rating | Employee Rating 5 | Employee Rating 3.7 | Employee Rating 3.7 |
Financial | |||
Net income | Net income ($3.7m) (FY, 2019) | Net income N/A | Net income ($25.9m) (FY, 2016) |
For sources of this data, please see the company profile
View company profiles
PLIVA
HQ
Zagreb, HR
PLIVA HRVATSKA is a pharmaceutical company focused on the development of generic and niche products.
View companyDeciphera Pharmaceuticals
HQ
Waltham, US
Employees
350↑ 37% increase
Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer.
View company